DOMS Q1 FY27: PAT falls 23% YoY to ₹45.3 Cr as raw material costs squeeze margins
PAT -23.4% YoY · revenue +19.25% · margins compressing
₹670.51 Cr
+19.25% YoY
₹45.28 Cr
-23.4% YoY
6.71%
-3.7pp YoY
₹7.33
DOMS Industries' consolidated revenue rose 19.3% YoY to ₹670.51 Cr (and 11.0% QoQ from ₹603.98 Cr) — near the top of management's 17-20% FY27 revenue growth guidance from the last concall. But consolidated PAT fell 23.4% YoY to ₹45.28 Cr (₹59.10 Cr a year ago) and 22.2% QoQ (₹58.20 Cr), so the quarter reads as a profitability miss riding on top of an on-plan topline.
Q1 FY-2027 vs prior quarters
The entire story sits on the cost line: cost of materials consumed rose 35.3% YoY to ₹369.86 Cr, outpacing revenue growth by roughly 16 points and pushing materials cost to 55.2% of revenue from 48.6% a year ago. Consolidated operating margin (EBITDA/revenue, ex-other income) compressed to 12.31% from 17.56% YoY and 16.71% QoQ — a roughly 525bps YoY contraction — while net margin fell to 6.75% from 10.43% YoY. Employee costs (+23.4% YoY) and other expenses (+27.8% YoY) grew broadly in line with revenue and were not the driver; a lower finance cost (₹2.02 Cr vs ₹3.48 Cr YoY, on-reduced borrowings) partially offset but could not close the gap. The effective tax rate was stable near 26%, so none of the PAT miss came from tax.
The stock went into the print at ₹2,242, down 3% over the past month of trading.
For context: revenue is at a 6-quarter high.
What the summary numbers don't show
Standalone PAT ₹42.87 Cr (EPS ₹7.06), down a similar ~23% YoY — no material divergence from consolidated
Consolidated EPS ₹7.33 vs ₹9.35 (Q4 FY26) and ₹9.44 (Q1 FY26)
Management expects revenue to grow by 17% to 20% in FY27, reflecting continued momentum driven by planned capacity expansions and current demand trends. While near-term margins may face pressure due to raw material volatility, the company aims to mitigate this through calibrated pricing and cost efficiencies. Long-term
— This quarter: missed
Management's own prior guidance explicitly flagged 'near-term margins may face pressure due to raw material volatility,' to be mitigated 'through calibrated pricing and cost efficiencies' — this quarter confirms the pressure materialised, but at a magnitude (500+bps) that suggests the mitigation levers have not yet shown up in the numbers. No formal analyst consensus for this specific quarter was found in a web search (DOMS's Q1 FY27 concall with CFO Rahul Shah is scheduled for August 4, 2026, a day after this filing), so the print cannot be benchmarked against street numbers; vsStreet is left unknown rather than guessed. No management press release or MD&A commentary accompanied this filing beyond the board-outcome letter and the results statement itself. By segment, Stationery Products revenue grew 18.9% YoY with an operating margin of 13.4% (₹835.62 Cr... figures in lakhs: ₹83.56 Cr operating profit on ₹625.91 Cr revenue), while the Hygiene (Uniclan) segment grew revenue 23.7% YoY but its operating margin remains around 6.7% — still well short of management's stated ~10% long-term EBITDA target for that segment. Separately this quarter, promoter F.I.L.A. sold a 7% stake (~₹934.74 Cr) and the company won an appeal setting aside a ₹17.75 lakh tax penalty — neither has a P&L bearing.
W1
Whether operating margin recovers toward the ~17% band (17.56% a year ago, 12.31% now) as management's pricing/cost-efficiency actions take effect
W2
Reynolds Pens integration from Q2 FY27 — revenue/margin contribution once consolidated
W3
Uniclan (Hygiene) segment margin trajectory toward management's stated ~10% EBITDA target, versus 6.7% this quarter
Clean digital filing, unambiguous columns. Consolidated PAT is total net profit incl. NCI (₹0.79 Cr); owners' share ₹44.49 Cr. Consolidated Q1 FY26 base not fully comparable (Note 5): Super Treads Pvt Ltd consolidated only from Jun 1, 2025. Reynolds Pens acquisition (₹35 Cr/$3.7M) completed Jul 1, 2026 — no P&L impact this quarter, hits from Q2 FY27. Standalone tells the same story as consolidated (both PAT down ~23% YoY), no basis divergence.
Revenue on track, margins crumble under raw material inflation
The verdict, the claims that held up, the sharpest analyst exchanges, and the risks — the earnings call, decoded from the transcript.
Hold
confidence 6/10
Grade B
Hit revenue guidance; missed margin guidance. Withdrew specific margin targets; visibility admitted limited. Strategy coherent, execution credible on capex.
Cautiously Optimistic
next 1–2 quarters
Optimistic
multi-year
DOMS nailed revenue (+19.2% on guidance) but margin collapse (-530 bps to 12.3% EBITDA) signals structural pressure under RM volatility. Management's volume-first strategy sacrifices near-term profitability. Recovery hinges on RM price stabilization and capacity ramp—both uncertain near-term. Long-term positioning solid, but FY27–28 profitability at risk.
₹670.5 Cr
Revenue · +19.2% YoY₹45.3 Cr
Reported PAT · −23.4% YoYCompressing
Margins · vs guidance: MixedDid the claims hold up?
Revenue grew 19.2% in line with annual guided range
METDelivered ₹670.5 Cr (+19.2% YoY); prior guidance was 17–20%. Hit upper-mid range.
Margin compression is temporary blip, not structural deterioration
OVERSTATEDEBITDA margin fell 530 bps (17.6%→12.3%); PAT fell 23.4% despite revenue +19.2%. Claim depends on RM prices normalizing—unverified at call time.
All core categories witnessed healthy growth
METScholastic, office supplies, art materials grew; e-commerce/modern trade strong. Export flattish due to West Asia. Claim supported by narrative.
Passed 4–5% price hikes to offset 20% raw material inflation
METRM prices up ~20%; company raised prices 4–5%, leaving ~500 bps unrecovered. Trade-off for volume/market share acknowledged.
Reynolds will contribute ~10% of revenues by FY29
MISSPrior Reynolds revenue ₹130–140 Cr; company targeting 10% of total (implies ~₹900+ Cr base). Capacity-constrained, not incremental volume.
Earnings quality
What changed since the last call
Margin guidance withdrawn
DowngradePrior target 16–17% EBITDA; Q1 delivered 12.3%. Visibility now limited due to RM volatility. De facto removal of specific margin guide.
Sales growth guidance narrowed and reinforced
NeutralPrior range 17–20%; call reinforced 18–20% for FY27. Upper end of prior range, not a raise, signalling confidence in volume but caution on upside.
Reynolds upside tempered
DowngradeManagement clarified Reynolds is capacity diversion, not incremental volume. No significant FY27 revenue lift. 10% of revenues by FY29 (not 20% as some misheard).
Price hike strategy locked in (no escalation planned)
NeutralManagement reinforced 4–5% price increases taken; no further hikes planned Q2. Will wait for RM stabilization. Strategic choice to defend market share over near-term margin.
The Q&A
Analysts pressed hard on why not take higher price hikes; management defended volume-led strategy citing market share gains vs unorganized players. Some skepticism on Reynolds incrementality, capacity constraints. Management held position; tone confident but cautious on RM outlook.
Margin trajectory — Kunal Vora, BNP Paribas
AnsweredYes, acknowledged temporary weakness. Once RM prices stabilize and new capacity ramps, margins will recover to 16–17% range. No further near-term price hikes planned.
Reynolds revenue outlook — Kunal Vora, BNP Paribas
AnsweredReynolds did ₹130–140 Cr prior. Target ~10% of company revenues by FY29. FY28 contribution marginal; capacity is diverted from DOMS, not incremental.
One-off cost quantification — Sneha, Nuvama Group
AnsweredESOP +0.2%, facility event +0.4%. RM inflation 20%, passed 4–5%, gap ~500 bps. Expects moderation in RM prices.
Pricing strategy rationale — Jinesh Joshi, PL Capital
AnsweredHistorical precedent: aggressive pricing during inflationary cycles allows small unorganized players breathing space. Strategy is to reduce that space via calibrated pricing and gain shelf space. Priority is volume-led growth, not near-term margin.
Reynolds nib business rationale — Jinesh Joshi, PL Capital
AnsweredNewell Group (Reynolds owner) wanted to retain tip manufacturing for global brands (Paper Mate, Sharpie, Parker). DOMS is setting up own tip plant; targeting 30–40% in-house manufacturing over 2 years.
Crude salience by segment — Aradhana Jain, 360 ONE Capital
PartialUniclan imports with long-term purchase orders at pre-agreed prices; lag effect means Q1 cost increase will hit Q2. Core stationery sourced locally, no lag.
Export challenges — Aradhana Jain, 360 ONE Capital
AnsweredMerchant exporters based in West India were impacted by global disruptions. Overall export decline (~12% of sales) flowed through. No structural regional mix change.
Capex efficiency and sales conversion — Rahul Agarwal, Ikigai Asset
AnsweredHistorical target ₹1 capex → ₹3 sales; achieved ~2.7x last year. 300K sq ft will ramp over 18–24 months to full utilization; part of 18–20% FY27 growth plan.
FY28 margin math — Rahul Agarwal, Ikigai Asset
PartialIf RM prices stay at current spot levels, need 4–5% additional price hikes to recover. FY28 targeting return to 16% EBITDA margin range.
Reynolds incremental capex question — Percy, IIFL Capital
AnsweredPhysical space is constraining. 50-acre project + 11 acres adjacent are under development. Building completion takes time; capex is already aggressive but cannot be rushed.
Reynolds margin profile — Anchit Jalan, Goldman Sachs Asset Management
AnsweredReynolds historically lower margin (Newell absorbed high costs). Under DOMS management, will operate at DOMS margin structure (~16% EBITDA target).
Margin bottom confirmation — Anchit Jalan, Goldman Sachs Asset Management
PartialHopefully. One-time facility costs + ESOP identified. Diaper seasonal pickup Q2 onwards should help. Assumes no major Trump tariff surprises.
Industry pricing alignment — Nihal Shah, Prudent Corporate Advisory
AnsweredIndustry was waiting for DOMS' decision. After DOMS increased, peers followed with similar calibrated increases. No aggressive outliers.
Margin recovery plan — Nihal Shah, Prudent Corporate Advisory
AnsweredWill add value to products (innovation, features) rather than pocket margin. Principle: nothing at cost of margin, nothing at cost of market. FY26 margins are sweet spot to target going forward.
Guidance
FY27 consolidated sales growth 18–20%
HighReiterated on call. In line with prior 17–20% range. Anchored on volume from back-to-school, capacity expansion, new launches, modern trade acceleration.
Visibility limited owing to RM price volatility
LowPrior target 16–17% EBITDA abandoned. Q1 delivered 12.3%. Management expects recovery once RM stabilizes but refused specific FY27/FY28 margin targets.
₹250–275 Cr capex planned for FY27
HighAlready invested ₹100 Cr in Q1. 50-acre greenfield + adjacent 11 acres + Jammu facility under development. Capex earmarked for facility buildout, not incremental Reynolds capex.
Risks the call surfaced
Raw material cost inflation
HighRM prices jumped ~20% in Q1; company passed only 4–5%, leaving ~500 bps margin gap. Recovery hinges on RM price stabilization, which remains uncertain due to West Asia crisis.
Export revenue headwinds
MediumExport growth flattish in Q1 due to West Asia disruptions (logistics, freight, shipment deferrals) and EU demand softness amid inflation. West Asia contributes ~2% of sales; still not fully opened.
Regional sales concentration risk
MediumWest India revenues down ~₹46 Cr (~24% YoY) due to merchant exporter base concentration and export-linked exposure. Reveals reliance on export intermediaries in one region.
Capacity execution and ramp risk
Medium300K sq ft of 50-acre greenfield to be operational Q2 end; full utilization expected in 18–24 months. If market demand slows or capacity overshoots demand, ROI at risk.
Reynolds integration and profitability
MediumReynolds brand & assets acquisition integration is underway. FY27 contribution minimal; full potential unlock tied to 50-acre plant capacity commissioning Q2 end. If brand fails to gain traction or production costs exceed plan, value dilution risk.
Competitive pricing and market share defense
LowCompany chose 4–5% price hikes vs 20% RM inflation to defend market share against unorganized competitors. Strategy logic sound but creates margin trough lasting FY27–FY28.
Management
Score 7/10. Candid on margin pressures; transparent cost breakdowns (ESOP +0.2%, facility +0.4%, RM –400 bps). Detailed on strategy rationale. Limited hedging on RM outlook; deferred FY28 guidance appropriately. Hit FY27 revenue guidance (19.2%). Missed margin guidance (12.3% vs prior 16–17%). Capex on track (₹100 Cr invested Q1 of ₹250–275 Cr plan). Capacity expansion timeline credible.
1 · Q2 FY27
300K sq ft capacity operational; diaper seasonality ramp begins
2 · H2 FY27
New pencil, eraser, pen volumes ramp; export capacity utilization gains
3 · Q3–Q4 FY27
Reynolds manufacturing begins at 50-acre facility; capex peak
Long-term positioning solid, but FY27–28 profitability at risk.
Revenue on Track, Profit Falls 23%—Margins Withdrawn
DOMS hit its revenue guidance with 19% growth, yet reported profit collapsed 23% and management withdrew its margin target. The quarter reveals the hard edge of a volume-first strategy in a commodity-inflation regime: scale is working, but profitability won't recover until raw material prices stabilize.
+19.2%
hit 17–20% guidance
-23.4%
₹45.3 Cr vs ₹59.1 Cr prior
12.3%
-530 bps YoY from 17.6%
Withdrawn
was 16–17%, now 'visibility limited'
The headline gap is stark: DOMS notched 19% revenue growth and landed squarely in its 17–20% full-year guidance range. Yet profit fell 23% despite that volume win. And on the call, management declined to re-guide margins, saying visibility is limited due to raw material volatility. That withdrawal—from a prior 16–17% EBITDA target to no specific target—is the real story of the quarter.
The raw material inflation trap
DOMS faced ~20% raw material price inflation in Q1. It raised prices 4–5% to customers—a deliberate choice. The gap: roughly 500 basis points of margin unrecovered. Management's rationale was sound: aggressive pricing would hand breathing room to smaller, unorganized competitors and risk shelf space. The trade-off was explicit—volume over margin, near-term. But the result is a profit collapse despite scale growth, and a margin floor (12.3% EBITDA) that sits 530 basis points below prior-year.
Management's claims vs. what holds up
Revenue growth is on track with FY27 guidance of 17–20%
SupportedDelivered ₹670.5 Cr, +19.2% YoY. Hit upper-mid of prior guidance range.
Margin compression is temporary; recovery hinges on RM stabilization
OverstatedEBITDA margin fell 530 bps to 12.3%. Management abandoned specific margin targets, admitting 'visibility limited' due to RM volatility. Recovery contingent on external commodity prices beyond management control.
All core categories witnessed healthy growth
SupportedScholastic, office supplies, art materials, e-commerce, modern trade all showed strong momentum. Export flattish due to West Asia disruptions (not core demand weakness).
Reynolds will contribute ~10% of company revenues by FY29
ContradictedManagement clarified Reynolds (prior ₹130–140 Cr revenue baseline) is capacity diversion within DOMS, not incremental volume. FY27 contribution minimal. Target ~10% by FY29 assumes brand ramp, not organic growth.
What changed on this call
Margin guidance withdrawn: Prior target 16–17% EBITDA. Management now says visibility is limited due to RM price volatility and deferred any specific margin target. De facto downgrade to no guidance. Sales growth reinforced, not raised: Prior range 17–20%; call reinforced 18–20% for FY27. No raise—upper end of the old range. Signals confidence in volume but caution on upside. Reynolds role clarified as capacity diversion: Market had speculated Reynolds would be an incremental revenue pillar. Management clarified it's a brand-play within existing capacity; FY27 contribution immaterial. Full potential unlock hinges on 50-acre facility manufacturing ramp, expected Q2 end. Price hike strategy locked in: Management reinforced no further price hikes planned for Q2+. Will wait for RM stabilization before escalating. Strategic choice to defend shelf space over near-term margin expansion.
Revenue growth momentum intact at 19.2% YoY
Volume strategy driving market share gains vs. unorganized players
Capacity expansion on track; 300K sq ft ready Q2 end
PAT fell 23% despite revenue +19%—earnings quality deteriorating
Margin guidance withdrawn; recovery contingent on external commodity stabilization
500 bps unrecovered pricing gap; risk of further compression if RM elevated
Capacity ramp 18–24 months; execution and demand risk over medium-term
Risks, ranked by how much they should concern a holder
Raw material price volatility unresolved
High20% RM inflation; only 4–5% price pass-through. 500 bps margin gap remains. If RM stays elevated into FY28, no further pricing planned—margin headroom disappears. Recovery is binary.
Margin guidance withdrawal signals execution uncertainty
HighPrior 16–17% EBITDA target abandoned. Management now says 'visibility limited.' CFO punted on 'will margins recover in FY28?'—saying 'a little early to guide.' Suggests uncertainty on RM normalization timing.
Export revenue headwinds persist
MediumExport flat in Q1 due to West Asia geopolitical disruptions. West India sales down ₹46 Cr (~24% YoY) due to merchant exporter concentration. Export is ~12% of revenue; recovery timing uncertain.
Capacity ramp execution and demand dependency
Medium300K sq ft new capacity + 50-acre Reynolds facility under construction. Full utilization takes 18–24 months. If demand slows or oversupply emerges, capex ROI deteriorates. Historical 2.7–3x ratio not guaranteed.
Reynolds integration and profitability realization
MediumReynolds prior ₹130–140 Cr revenue. Full potential unlock depends on 50-acre facility manufacturing ramp (Q2 end target) and brand execution. If integration stutters, value dilution risk. FY27 contribution minimal.
Regional concentration: West India merchant exporter dependency
LowWest India down 24% YoY due to merchant exporter base hit by global disruptions. If regional recovery stalls, localized pressure to sales mix. Management clarified no structural change, but dependency is clear.
How the street is positioned
Price action: ₹2261.9 as of Aug 7. The day-1 pop was +0.5%; by day 3, +0.41%. Delivery was strong (87.1%), but the muted rally is telling. The street was braced for margin miss and did not reward headline revenue growth. This is the market's own verdict: earnings quality is impaired, and near-term recovery uncertain. Valuation context: Stock trades at ₹2261.9, down 17.9% from its all-time high of ₹2755 and up 11.76% from the 52-week low of ₹2023.9. It trades below its 50-day SMA (₹2266.66) and 200-day SMA (₹2371.63), signaling weakness. RSI 48.3 is neutral. Chart not yet oversold, but momentum is cautious. Institutional flows: FII ownership has declined from 9.08% (FY25 Q1) to 7.61% (FY26 Q4)—147 bps outflow over five quarters. DII ownership ticked up modestly from 15.82% to 19.14%, offsetting the FII exit. Promoters remain steady at 70.39%. FII exit on back of margin miss and guidance withdrawal is consistent with stock's muted post-result reaction. Insider/bulk activity: In mid-June 2026, FILA (Fabbrica Italiana Lapis—Newell Group entity, linked to Reynolds acquisition) sold 19.08L + 23.40L shares (~42.5L total) at ₹2200. Simultaneously, SBI Mutual Fund bought 5.83L + 3.49L shares, and Axis Mutual Fund bought 3.62L shares at same price. Pattern suggests founder-linked trim on strength while domestic mutual funds bought the dip. Insiders see fair value here but not confident in near-term upside.
1 · Q2 capacity commissioning and diaper seasonality ramp
300K sq ft expected operational Q2 end. Diaper seasonality pickup (Uniclan) should begin Q2+, aiding fixed-cost absorption. If EBITDA margin expands 100–150 bps due to capacity leverage + seasonal mix, it signals volume strategy is working. If margins stay flat or compress further, RM pressure persists.
2 · RM price trajectory and further pricing decisions
Management has locked in no further price hikes for Q2+. If RM prices stabilize or decline by Q2/Q3, management credibility on margin recovery improves. If RM stays elevated, 500 bps gap persists, and FY28 margins will require aggressive pricing (which risks shelf space). Watch management's tone on RM outlook.
3 · Export recovery once West Asia disruptions ease
Export is ~12% of revenue; West Asia disruptions drove Q1 flatness. If shipping normalizes and merchant exporter base in West India recovers, export growth should accelerate. This would restore 13–15% FY27 export target and cushion overall margin pressure via higher-margin export mix.
4 · Reynolds manufacturing ramp and contribution clarity
Management promised 50-acre facility operational Q2 end. Reynolds full potential unlock takes 18–24 months. By Q2/Q3, clarity on Reynolds manufacturing cost structure, brand traction, and FY28 revenue expectations will emerge. If incremental or just capacity diversion will become clear.
DOMS is a high-quality operator with strong market position and real volume momentum. But this quarter reveals a hard constraint: in commodity-inflation regimes, volume-led strategy alone does not protect profit. The collapse of PAT despite 19% revenue growth, and the withdrawal of margin guidance, signal that profitability is now an external-factors play. Recovery hinges almost entirely on RM prices stabilizing—something management cannot control.
Near-term (FY27–FY28), expect margin pressure to persist. Capacity is being built, but ramp takes time. The honest read is steady execution, not a step-change. The stock's flat post-result action and FII outflows reflect street skepticism on near-term recovery.
The single number to track from here is EBITDA margin. If it expands 100+ bps by Q2 (aided by capacity and seasonal mix), the recovery narrative gains traction. If it stays flat or compresses further, the margin risk is real, and the stock will face further pressure.